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Mari Ljungstr€om, MSc, Brjann Ljotsson, PhD, Eva Serlachius, PhDObjective: Cognitive-behavioral therapy (CBT) is the
ﬁrst-line treatment for young people with obsessive-
compulsive disorder (OCD), but most patients do not
have access to this treatment. Thus, innovative ways to
increase the accessibility of CBT are needed. The objective
of this trial was to evaluate the efﬁcacy of therapist-guided
internet-based CBT (ICBT) for adolescents with OCD.
Method: Sixty-seven adolescents (12–17 years old) with
OCD were randomly assigned to a 12-week clinician- and
parent-supported ICBT program (BiP OCD) or a waitlist
condition. The primary outcome was the Children Yale-
Brown Obsessive Compulsive Scale (CY-BOCS) adminis-
tered by blinded assessors before and after the interven-
tion. All patients were followed up 3 months after the
intervention.
Results: In intention-to-treat analyses, BiP OCD was
superior to waitlist on the CY-BOCS (time-by-group
interaction, B ¼ 4.53, z ¼ 3.74, p < .001; Cohen’s
d ¼ 0.69; 95% CI 0.19–1.18) and on most secondary
outcome measurements. Patients randomized to BiP
OCD also showed further improvement from post-
treatment to 3-month follow-up, with a within-groupThis article is discussed in an editorial by Drs. Kathleen Myers and
Ann Vander Stoep on page 5.
Supplemental material cited in this article is available online.
www.jaacap.orgpretreatment to follow-up effect size (Cohen’s d) equal
to 1.68 (95% CI 1.00–2.36). Patient satisfaction with BiP
OCD was high. There were no relevant adverse events.
Average clinician support time was 17.5 minutes per
patient per week.
Conclusion: Therapist-guided ICBT is a promising low-
intensity intervention for adolescents with OCD and has
the potential to increase access to CBT. It might be
particularly useful in a stepped-care approach, in which a
large proportion of patients with moderately severe OCD
could ﬁrst be offered ICBT, thus freeing limited resources
for more complex cases.
Clinical trial registration information—Internet-Deliv-
ered CBT for Adolescents With OCD: A Randomized
Controlled Study (BiPOCD); http://clinicaltrials.gov;
NCT02191631.
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J Am Acad Child Adolesc Psychiatry 2017;56(1):10–19.bsessive-compulsive disorder (OCD) is a psychi-
atric disorder characterized by recurrent anxiety-O provoking thoughts and compulsive behaviors.1
OCD has a prevalence of 0.25% to 2% in children and ado-
lescents2,3 and is associated with impairments in academic,
social, and family functioning.3 Symptoms usually begin in
childhood4,5 and are associated with increased risk of future
mental health problems in adulthood.6,7 OCD often has a
chronic course if untreated.4 In consequence, early detection
and treatment is crucial for long-term outcome and pre-
vention of prolonged suffering.8Cognitive-behavioral therapy (CBT) is the ﬁrst-line
treatment for pediatric OCD according to international
treatment guidelines.9,10 Although pediatric OCD can be
effectively treated with CBT,11 few patients actually have
access to this treatment.4 Availability of evidence-based
assessment and treatment differs regionally12 and a sub-
stantial majority of cases are not detected.13 Moreover, cases
that are detected rarely receive adequate CBT.14 Innovative
ways to disseminate effective treatments more broadly are
clearly needed to overcome those treatment barriers.
Internet-delivered CBT (ICBT) has the potential to make
evidence-based treatments more accessible, because it is less
restricted by temporal and geographic barriers. In ICBT, the
patient works with web-based treatment materials and
online homework assignments, closely resembling an
online self-help book, but often supported by a clinician.15
Although other electronic health formats have shown
potential to effectively bridge geographic distances, such asJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
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INTERNET-DELIVERED CBT FOR ADOLESCENT OCDweb camera-delivered CBT16,17 and CBT delivered by tele-
phone,18 those formats still require booked appointments
between patient and therapist and thus offer limited time-
and cost-saving opportunities. Because ICBT requires only
minimal, asynchronous clinician support (often a fraction of
the time needed in face-to-face CBT),19 it offers potential
time- and cost-saving opportunities for therapists and health
care providers. There is a growing body of evidence sup-
porting the efﬁcacy of ICBT in adult patient populations,
with currently more than 100 randomized controlled trials
(RCTs) of various psychiatric disorders.19 Nonetheless,
research on ICBT for children and adolescents has been
lagging behind; a recent review of ICBT for mood and
anxiety disorders in all age groups found 52 RCTs, of which
only 4 involved children or adolescents.20 A previous RCT in
adolescents with anxiety disorders (excluding OCD) evalu-
ated ICBT compared with face-to-face CBT and a waitlist
control and found ICBT was superior to the waitlist (effect
size 1.45) and no signiﬁcant differences between ICBT and
face-to-face CBT.21
Three previous RCTs have demonstrated efﬁcacy of ICBT
for adult OCD, with large between-group treatment effects
compared with no-treatment control conditions and 47% to
60% of patients with clinical signiﬁcant improvement. The
mean total therapist time in ICBT was approximately 10 to
15 minutes per patient per week.22-24 Although the efﬁcacy
of ICBT has been demonstrated in adults, the generaliz-
ability of these results to pediatric patients cannot be auto-
matically assumed, given important developmental,
cognitive, and motivational aspects that distinguish children
from adults. Our research group recently developed a
12-week therapist-guided ICBT protocol for pediatric OCD
including parent support and pilot tested it in an open trial
with 21 adolescents.25 Results showed signiﬁcant decreases
in OCD symptoms with large within-group effect sizes
(Cohen’s d ¼ 2.29). The results were sustained at 6-month
follow-up, and the patients rated the treatment format as
overall acceptable.
Based on the encouraging results from the pilot study, the
logical next step was a more rigorous evaluation of the
intervention. We conducted a single-blinded RCT to eval-
uate the efﬁcacy of therapist-guided ICBT for adolescents
with OCD. Because most patients currently do not have
access to CBT, we used a waitlist comparison and allowed
for continued usual care or medication, if relevant. We also
evaluated the safety and acceptability of the treatment.
METHOD
Study Design
This study was a 12-week, single-blinded, clinical RCT with patients
allocated to ICBT or a waitlist control condition. Patients in the
control condition were invited to cross over to ICBT after the post-
intervention assessment. The study was carried out at the Child and
Adolescent Psychiatry Research Center in Stockholm, Sweden,
which is a clinical research unit within the regional child and
adolescent mental health service. Primary and secondary outcomes
were measured at baseline (week 0), postintervention (after
12 weeks), and 3-month follow-up. The study was approved by the
regional ethics review board in Stockholm (2014/673-31/2).JOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
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Inclusion criteria were a primary diagnosis of OCD as deﬁned by the
DSM-5,1 a total score of at least 16 on the Children’s Yale-Brown
Obsessive-Compulsive Scale (CY-BOCS),26 age 12 to 17 years old,
ability to readandwrite inSwedish,daily access to the internet, 1parent
who could co-participate in the treatment, and for patients on
psychotropic medication, a stable dose for the past 6 weeks before
baseline assessment. Exclusion criteria were diagnosed autism spec-
trum disorder, psychosis, bipolar disorder, or severe eating disorder;
suicidal ideation; ongoing substance dependence; inability to read
or understand the basics of the ICBT material; completed CBT for
OCD within the past 12 months (deﬁned as 5 sessions of CBT
including exposure and response prevention); and ongoing psycho-
logical treatment for OCD or another anxiety disorder.
Procedures
Patients were recruited from all over Sweden. The study was
advertised in the media, mental health care services, primary care,
and patient organizations. Interested families registered on the
study home page (http://www.bup.se/bip) or, if located in the
Stockholm area, were referred to the study by their local child and
adolescent mental health unit. Figure 1 presents an overview of the
study ﬂow.
Screening procedures were carried out in 2 steps: telephone
interview and in-person assessment. The initial telephone interview
was conducted by a clinician with the parent or primary caregiver to
make a preliminary assessment of inclusion and exclusion criteria.
Potentially suitable applicants were given an appointment with a
clinician who conducted a full diagnostic interview using the Mini-
International Neuropsychiatric Interview for Children and Adoles-
cents (MINI-KID)27 and administered the CY-BOCS.26 Participants
meeting full inclusion criteria were given verbal and written infor-
mation about the study. After signed consent by the primary care-
giver and adolescent, the patients conducted the remaining baseline
assessments and were randomly assigned to ICBT or the control
condition.
Postintervention assessment with clinician-rated measurements
and self-reports was conducted immediately after treatment or the
waitlist period of equivalent duration. Postintervention interviews
were conducted by raters blinded to randomization status. Patients
in the control group were invited to cross over to ICBT immediately
after the postintervention assessment and were reassessed after
12 weeks of ICBT. Follow-up measurements were performed 3
months after ICBT.
Randomization and Masking
A randomization sequence was created according to block
randomization procedures (computerized random numbers; http://
www.random.org) before the start of inclusion. Patients were ran-
domized at a 1:1 ratio to ICBT or the waitlist. The allocation of
patients was concealed by opaque sealed envelopes containing each
allocation. Assessors at pre- and postintervention were unaware of
the group allocation. At the postintervention assessment, the raters
were asked to guess which group they believed the patient was
randomized to and whether this was a random guess (41%), acci-
dentally disclosed by the patient (3%), or due to clinical improve-
ment (56%). Blinded raters’ guesses were correct in 69.7% of cases
and a signiﬁcant predictor of group allocation (z ¼ 3.14, p ¼ .002).
However, raters were not signiﬁcantly better than chance in
detecting group allocation when clinician-rated improvement
(Clinical Global Impression–Improvement [CGI-I]) was held as a
covariate to control for OCD symptom changes as a reason for
correct guesses (z ¼ 1.46, p ¼ .144).www.jaacap.org 11
FIGURE 1 Study flow. Note: ICBT ¼ internet-delivered cognitive-behavioral therapy.
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LENHARD et al.Intervention
The clinician- and parent-supported ICBT program (BiP OCD) was
initially pilot tested in a previous study25 and was developed in line
with expert guidelines, with exposure and response prevention
(ERP) as the main treatment component.28 The intervention is
designed for adolescents 12 to 17 years old and consists of 12
chapters (Table 1) that contain texts to read, ﬁlms and animations to
watch, and exercises for the patients to do on their own and with
their parents (sample screenshots are presented in Figure S1, avail-
able online). The age span 12 to 17 years was chosen in consideration
of the developmental needs and abilities of adolescents to work
relatively independently under appropriate supervision from par-
ents and a clinician.
Patients log in to the treatment using a personal password-
secured account. BiP OCD is divided into 3 different phases, with
phase 1 presenting psychoeducation regarding OCD and the ratio-
nale for cognitive-behavioral interventions. Phase 2 is the main part
of treatment and introduces ERP exercises and cognitive strategies.
Phase 3 addresses problem solving and relapse prevention. Patients12 www.jaacap.orghave regular asynchronous contact with the clinician through mes-
sages (resembling e-mail) and occasionally by telephone. The treat-
ment is supported by a smartphone application with which patients
have the possibility to add and edit exposure tasks and set
reminders for ERP (Figure S1, available online).
Parents log in to a separate track of the treatment that covers
parent-speciﬁc topics divided into 5 chapters covering content on
family accommodation, parental coping strategies, and support of
ERP. The degree of parental involvement is dependent on the
developmental needs of the adolescent, with more degrees of
freedom for older patients. Parents and patients are encouraged to
carry out ERP exercises together and report back to the clinician.
Treating clinicians were 6 trained psychologists with experience
in treating pediatric OCD and ICBT. Clinician time spent on each
patient was automatically logged by the platform.
Measurements
Clinician-Administered Measurements. The CY-BOCS26 is a semi-
structured clinician-administered interview and considered the goldJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
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TABLE 1 Treatment Chapters and Content of Clinician- and Parent-Supported Internet-Based Cognitive-Behavioral Therapy (ICBT)
Program (BiP) for Obsessive-Compulsive Disorder (OCD)
Treatment Phase Chapter Adolescent Chapters Parent Chapters
Psychoeducation 1 Introduction to ICBT Introduction to ICBT
2 Psychoeducation about OCD Psychoeducation about OCD
3 Functional analysis: the OCD circle
4 Building an exposure hierarchy
ERP 5 Rationale for ERP Rationale for ERP
6 Testing ERP Parental ERP coaching strategies
7 New steps with ERP
8 ERP—frequent problems and solutions OCD and family accommodation
9 More new steps with ERP
10 Coping with obsessions
Relapse prevention 11 Final ERP exercises
12 Relapse prevention and lessons learned
Note: ERP ¼ exposure with response prevention.
INTERNET-DELIVERED CBT FOR ADOLESCENT OCDstandard in the assessment of symptom severity in pediatric OCD.
The CY-BOCS was the primary outcome measurement in this study.
To ensure the reliability of the primary outcome measurement, all
clinicians were trained in CY-BOCS assessments and had regular
meetings discussing taped interviews from the study sample.
Furthermore, all baseline and postintervention CY-BOCS interviews
were taped, and a random sample of 20% (n ¼ 13) was blindly
re-rated. The intra-class coefﬁcient (absolute agreement) in the
sample was 0.91 (p < .001), which reﬂects excellent inter-rater
agreement according to statistical guidelines.29 The Clinical Global
Impression–Severity (CGI-S)30 is a brief clinician rating of symptom
severity. The graded scale ranges from 1 (no symptoms) to 7
(extremely severe). The CGI-I31 is a brief clinician rating of the pa-
tient’s symptom severity change from the basement assessment. The
graded scale ranges from 1 (very much improved) to 7 (very much
worse).
Self- and Parent-Report Measurements. The Children’s Obsessional
Compulsive Inventory–Revised (ChOCI-R)32 is a self- and parent-
report measurement of pediatric OCD symptom severity. The
Education, Work and Social Adjustment Scale–Child and Parent
Version (EWSAS) is an adaptation of the Work and Social Adjust-
ment Scale33 for children and adolescents and measures the degree
of impairment in 5 different areas of functioning (school, everyday
situations, social activities, leisure time, family, and relationships).
The Spence Child Anxiety Scale–Short Version–Child and Parent
Version (SCAS-S-C/P)34 is a child and parent self-report measure-
ment of anxiety-related psychopathology. The Child Depression
Inventory–Short Version (CDI-S)35 is a 10-item short version of the
CDI and measures symptom severity of depression in adolescents.
The Family Accommodation Scale, Parent-Report (FAS-PR)36 is a
parent-report measurement of accommodation behaviors of parents
with a child with OCD.
Adverse Events
After completing ICBT, patients were asked to complete a web-
based form on the occurrence of any adverse events as a reaction
to or consequence of the intervention. Severity of events was rated
by the patients and was evaluated by a clinical psychologist.
Statistical Analyses
With a predetermined sample size of 33 in each condition, this study
was powered to detect an effect size (Cohen’s d) equal to 0.8 withJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
VOLUME 56 NUMBER 1 JANUARY 201790% power and a signiﬁcance level of an a value equal to 0.05.
Intention-to-treat mixed-effects regression analyses for repeated
measures were conducted. Mixed-effects models use all available
data in longitudinal study designs and can handle missing data.37
For continuous outcome measurements, the models included ﬁxed
effects of time (pre- and posttreatment), group (ICBT versus control),
and the interaction effect of time by group. Subject and time were
added as random effects to account for individual variation
over time.
Effect sizes on primary and secondary outcomes are reported
as Cohen’s d ¼ (mean 1  mean 2)/pooled standard deviation
[SD], and within-group effect sizes were corrected for correlations
between time points.38 Ordinal data were analyzed using
ordinal regression, binary data were analyzed using logistic
regression or c2 or Fisher exact tests, and paired binary data
were analyzed with McNemar tests. Dichotomized outcomes
were operationalized in line with expert consensus as follows:
treatment response was deﬁned as a symptom decrease of at least
35% on the CY-BOCS plus a CGI-I rating of 1 (very much
improved) or 2 (much improved) lasting for at least 1 week.
Remission was operationalized as a CY-BOCS total score no
higher than 12 plus a CGI-S rating of 1 (normal, not at all ill) or 2
(borderline mentally ill) lasting for at least 1 week.39 All analyses
were conducted in STATA 13 (STATA Corporation, College Sta-
tion, TX).
RESULTS
Sample Characteristics and Study Flow
Sixty-seven patients were recruited from all over Sweden
from August 2014 through June 2015. The median travel
distance from patients’ homes to our clinic was 18 km (range
1–470 km). Table 2 presents baseline characteristics of the
sample. The 2 groups did not differ signiﬁcantly on any
demographic or clinical variables.
Figure 1 displays the patient ﬂow. The CY-BOCS showed
a 1% loss of data at posttreatment, a 6% loss at 3-month
follow-up, and an 11% loss at posttreatment for patients
who had crossed over to ICBT after waitlist. For the sec-
ondary outcomes, self-rated outcome data loss rates were
11% and 36% for the adolescent-rated measures at the post-
treatment and 3-month follow-up points and 6% and 30%www.jaacap.org 13
TABLE 2 Sample Characteristics
Control (n ¼ 34) ICBT (n ¼ 33) Total (N ¼ 67)
Girls, % 41 52 46
Age (y), mean (SD) 14.97 (1.66) 14.21 (1.69) 14.60 (1.71)
Country of birth, %
Sweden 88 97 93
Other European country 6 3 4
Asian 6 0 3
Parent’s educational level, %
Primary 0 3 1
High school 29 21 25
College 3 6 4
Vocational 6 3 4
University 50 48 49
Doctoral degree 0 3 1
Other 12 15 13
Travel distance to study site (km), median (maximum) 18.5 (470) 18 (433) 18 (470)
CY-BOCS total baseline score, mean (SD) 22.12 (3.91) 23.00 (4.31) 22.55 (4.10)
Age at OCD onset (y), mean (SD) 11.41 (3.01) 9.63 (2.32) 10.55 (2.82)
Comorbidity, %
Depression 6 9 7
Dysthymia 0 6 3
Panic anxiety disorder 3 12 7
Social anxiety disorder 3 15 9
Speciﬁc phobia 18 9 13
Generalized anxiety disorder 18 9 13
PTSD 3 0 1
Tourette’s syndrome, tics 9 3 6
ADHD 6 12 9
Comorbid diagnoses (n), %
0 53 61 57
1 35 21 28
2 9 9 9
3 3 6 4
4 0 3 1
Previous treatment experience, %
None 59 52 55
CAMHS counseling 29 42 36
CAMHS CBT 12 0 6
CAMHS psychodynamic 0 6 3
Previous OCD treatments, %
None 74 73 73
CBT 24 27 25
General counseling 3 0 1
Medication (ongoing), %
None 82 72 78
SSRI 18 18 18
Stimulants 3 6 4
Tricyclic antidepressants 0 3 1
Type of referral, %
Self-referral 91 94 93
CAMHS referral 9 6 7
Note: ADHD ¼ attention-deficit/hyperactivity disorder; CAMHS ¼ Child and Adolescent Mental Health Service; CBT ¼ cognitive-behavioral therapy;
CY-BOCS ¼ Children’s Yale-Brown Obsessive Compulsive Scale; ICBT ¼ internet-delivered cognitive-behavioral therapy; OCD ¼ obsessive-compulsive disorder;
PTSD ¼ posttraumatic stress disorder; SD ¼ standard deviation; SSRI ¼ selective serotonin reuptake inhibitor.
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INTERNET-DELIVERED CBT FOR ADOLESCENT OCDfor the parent-rated measures at posttreatment and 3-month
follow-up points. Logistic regression analyses with missing
status (yes versus no) as the outcome and baseline variables
as predictors showed no signiﬁcant associations, indica-
ting nonsystematic data loss. Similarly, the Little test
indicated that missing data were randomly distributed
(c228[N ¼ 67] ¼ 28.64, p ¼ .43).Primary Outcomes
At posttreatment, the ICBT group had signiﬁcantly lower
CY-BOCS total scores compared with the waitlist group
(B ¼ 4.53, z ¼ 3.98, p < .001), corresponding to a mod-
erate between-group effect size (Cohen’s d) equal to 0.69
(Table 3, Figure 2, and Table S1, available online).
The ICBT group continued to show improvement from
posttreatment to 3-month follow-up (B ¼ 2.52, z ¼ 3.03,
p ¼ .002), with a within-group effect size (Cohen’s d) from
pretreatment to 3-month follow-up equal to 1.68. The study
protocol allowed patients to seek other treatments during
the follow-up period. Seventy-seven percent (n ¼ 24) had
not initiated any new treatments at the 3-month follow-up,
6% (n ¼ 2) had initiated a new course of CBT, 6% (n ¼ 2)
had psychological counseling, 3% (n ¼ 1) began treatment
with a selective serotonin reuptake inhibitor, and 6% (n ¼ 2)
began treatment with a central stimulant medication.
Exclusion of those patients who had additional treatments
only minimally modiﬁed the posttreatment to follow-up
result (B ¼ 2.29, z ¼ 2.46, p ¼ .014).Treatment Response and Remission
Using strict consensus criteria,39 9 patients (27%) in the ICBT
group and none (0%) in the control group were classiﬁed as
responders at posttreatment. At 3-month follow-up, 10 pa-
tients (32%) in the ICBT group were classiﬁed as responders.
At posttreatment, 5 patients (15%) in the ICBT group
were classiﬁed as being in remission compared with 0 (0%)
in the control group. At 3-month follow-up, 8 patients (26%)
in the ICBT group had reached remission.Secondary Outcomes
Ordinal regression analyses showed a signiﬁcant difference
favoring ICBT on the CGI-I (B ¼ 2.29, z ¼ 4.20, p < .001) and
CGI-S (B ¼ 1.71, z ¼ 3.12, p ¼ .002). A signiﬁcant time-
by-group effect favoring ICBT was found for self- and
parent-rated OCD symptom severity (ChOCI-R, B ¼ 4.35,
z ¼ 2.46, p ¼ .014; B ¼ 5.24, z ¼ 2.53, p ¼ .012,
respectively). For the remaining self-rated outcomes—
depression (CDI-S), anxiety (SCAS-S-C), and functional
impairment (EWSAS-C)—no signiﬁcant time-by-group
effects were detected. However, there was a delayed treat-
ment effect from post-measurement to 3-month follow-up
on self-rated anxiety (SCAS-S-C, B ¼ 2,77, z ¼ 2.72,
p ¼ .007) and functional impairment (EWSAS-C, B ¼ 4.46,
z ¼ 2.55, p ¼ .011) in the ICBT group. For parent-rated
outcomes, there was a signiﬁcant time-by-group effect
favoring ICBT on anxiety (SCAS-S-P, B ¼ 3.30, z ¼ 2.90,
p ¼ .004), functional impairment (EWSAS-P, B ¼ 6.25,JOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
VOLUME 56 NUMBER 1 JANUARY 2017z ¼ 3.72, p < .001), and family accommodation (FAS-PR,
B ¼ 5.40, z ¼ 2.98, p ¼ .003).
Waitlist Crossover to ICBT
All 34 patients on the waitlist were offered ICBT after
12 weeks, and 28 accepted (Figure 1). There was a signiﬁcant
change on the CY-BOCS for patients who received ICBT
after waitlist (B ¼ 5.86, z ¼ 5.17, p < .001), with a large
within-group effect size (Cohen’s d) equal to 1.14 (95% CI
0.48–1.81). Patients’ pretreatment CY-BOCS total scores
decreased from a mean value equal to 20.75 (SD 3.78) to 15.0
(SD 6.42) after treatment (Figure 2). Ten patients (40%) were
classiﬁed as treatment responders and 7 (28%) were in
remission at posttreatment. We also observed additional
signiﬁcant treatment gains from posttreatment to 3-month
follow-up (B ¼ 2.49, z ¼ 2.18, p ¼ .029), a CY-BOCS
mean total score equal to 12.56 (SD 6.81), and 13 patients
(52%) classiﬁed as responders and 11 (44%) as in remission.
The within-group pretreatment to follow-up effect size
(Cohen’s d) was equal to 1.51 (95% CI 0.79–2.22).
Treatment Completion, Clinician Times, and Satisfaction
The mean number of chapters completed by the patients was
8.52 (SD 2.94) of 12 chapters in total. Chapters 1 to 5 covered
the main components of the treatment (psychoeducation and
ERP), and those chapters were completed by 97% of patients.
Twenty-seven percent (n ¼ 9) completed all 12 chapters. Post
hoc analyses showed that the number of completed chapters
was not signiﬁcantly correlated with the CY-BOCS total
score at baseline, with age, or with parental educational
status and did not predict the CY-BOCS score at post-
intervention. The average clinician time per patient per
week, including reading patient exercises, written feedback
and telephone calls, was 17.5 minutes (SD 7.6).
On an ordinal Likert-type scale, 46% of adolescents
reported they were satisﬁed with the internet-delivered
format, 50% were satisﬁed with the internet format most
of the time but would have liked to meet with a clinician
occasionally, and 4% would have preferred face-to-face
treatment. Overall, patients rated BiP OCD as bad (0%),
OK (36%), good (32%), or very good (32%).
Safety
Similar occurrences of adverse events were reported in the 2
groups at the postintervention time point (23% of waitlist
group, 29% of ICBT group; c21 ¼ 0.21, p ¼ .65). The types of
reported adverse events were mood problems (9%), OCD-
related symptoms (6%), anxiety (4%), and sleep problems
(1%). No category of events was more common in either
group (Fisher exact test, p ¼ .55). None of the reported
incidents were rated as severe or unexpected.DISCUSSION
To the best of our knowledge, this is the ﬁrst controlled trial
to evaluate the efﬁcacy of therapist-guided ICBT for ado-
lescents with OCD. ICBT yielded signiﬁcant symptom de-
creases on clinician-, self-, and parent-rated OCD symptomwww.jaacap.org 15
TABLE 3 Primary and Secondary Continuous Outcomes of the Intention-to-Treat Sample
Unadjusted Mean (Standard Deviation) Effect Sizes, Cohen d (95% CI)
p Value for Time
 GroupPretreatment Posttreatment
3-Mo
Follow-Up
Within-Group
Pre-Post
Within-Group
Pre-Follow-Up
Between-Group
ICBT vs. WL
Clinician measurement
CY-BOCS
ICBT 23.00 (4.31) 16.97 (6.29) 14.23 (5.90) 1.09 (0.60 to 1.58) 1.68 (1.00 to 2.36) 0.69 (0.19 to 1.18) <.001
Waitlist 22.12 (3.91) 20.64 (4.11) 0.38 (0.01 to 0.76)
Self-ratings
ChOCI-R-C
ICBT 24.48 (6.72) 19.96 (7.83) 19.33 (8.25) 0.57 (0.16 to 0.98) 0.93 (0.33 to 1.53) 0.64 (0.11 to 1.16) .014
Waitlist 25.38 (7.71) 24.68 (6.93) 0.03 (0.40 to 0.33)
CDI-S
ICBT 4.67 (3.38) 4.61 (3.96) 4.71 (4.19) 0.06 (0.20 to 0.31) 0.31 (0.10 to 0.72) 0.01 (0.52 to 0.50) .247
Waitlist 4.29 (3.42) 4.58 (4.37) 0.14 (0.33 to 0.05)
SCAS-S-C
ICBT 12.85 (6.42) 11.36 (7.41) 10.43 (6.38) 0.22 (0.04 to 0.48) 0.59 (0.04 to 1.14) 0.27 (0.25 to 0.78) .118
Waitlist 13.03 (6.38) 13.13 (5.73) 0.08 (0.32 to 0.15)
EWSAS-C
ICBT 14.79 (9.15) 12.79 (9.73) 10.67 (9.13) 0.27 (0.06 to 0.59) 0.79 (0.14 to 1.43) 0.27 (0.24 to 0.78) .142
Waitlist 15.15 (9.85) 15.39 (9.48) 0.06 (0.35 to 0.22)
Parent ratings
ChOCI-R-P
ICBT 24.42 (7.56) 19.32 (9.88) 17.65 (8.69) 0.68 (0.18 to 1.18) 0.70 (0.20 to 1.20) 0.59 (0.09 to 1.10) .012
Waitlist 25.56 (8.36) 25.25 (10.04) 0.06 (0.19 to 0.30)
SCAS-S-P
ICBT 10.70 (5.79) 8.26 (5.85) 8.35 (5.62) 0.48 (0.17 to 0.79) 0.33 (0.01 to 0.68) 0.67 (0.16 to 1.17) .004
Waitlist 11.76 (5.81) 12.22 (5.99) 0.10 (0.38 to 0.18)
EWSAS-P
ICBT 16.12 (8.61) 11.35 (8.54) 11.13 (9.21) 0.60 (0.21 to 0.99) 0.57 (0.27 to 0.87) 0.43 (0.07 to 0.93) <.001
Waitlist 14.15 (9.28) 15.47 (10.32) 0.09 (0.31 to 0.13)
FAS-PR
ICBT 15.79 (11.25) 11.23 (9.20) 10.57 (10.18) 0.41 (0.11 to 0.71) 0.54 (0.24 to 0.84) 0.54 (0.04 to 1.04) .003
Waitlist 16.18 (10.93) 17.13 (12.27) 0.06 (0.27 to 0.16)
Note: CDI-S ¼ Child Depression Inventory short version; ChOCI-R-C/P ¼ Children’s Obsessional Compulsive Inventory Revised, Child/Parent Version; CY-BOCS ¼ Children’s Yale-Brown Obsessive Compulsive Scale;
EWSAS-C/P ¼ Education, Work and Social Adjustment Scale Child/Parent Version; FAS-PR ¼ Family Accommodation ScaleeParent Report; SCAS-S-C/P ¼ Spence Child Anxiety Scale short version for children/
parents; ICBT ¼ internet-delivered cognitive-behavioral therapy.
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FIGURE 2 Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS) total scores with 95% CIs for A) internet-delivered
cognitive-behavioral therapy (ICBT) and waitlist randomization and B) waitlist cross-over. Note: 3m FU ¼ 3-month follow-up.
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INTERNET-DELIVERED CBT FOR ADOLESCENT OCDmeasurements with moderate effect sizes compared with the
waitlist control. Patients continued to show signiﬁcant
improvement from posttreatment to 3-month follow-up.
Patients initially randomized to the waitlist condition, and
who remained largely unimproved after 12 weeks, were
later crossed over to ICBT and showed a similar and sig-
niﬁcant decrease of symptoms. Additional improvements
were observed in secondary outcome measurements. Clini-
cians spent, on average, 17.5 minutes per patient per week
supporting the families. Satisfaction with the delivery format
was high, although approximately half the sample reported
they would have liked occasional face-to-face clinician con-
tact. There were no serious adverse events.
The present study extends the ICBT trials performed in
adult patients with OCD, which have demonstrated the
feasibility and efﬁcacy of this approach.22,23 Interestingly,
although using analogous primary outcomes (the [C]Y-BOCS
at posttreatment), the magnitude of effects found in the adult
studies (between-group Cohen’s d range 1.12–1.57) exceeded
those of the present study. Similarly, effect sizes, responder
rates, and remission rates appeared to be somewhat lower
than those typically found in face-to-face CBT for pediatric
OCD. A recent meta-analysis showed a large treatment effect
size (g ¼ 1.21) of standard CBT compared with active control
or waitlist control, with approximately 70% of treatment
responders andmore than half the patients being in remission
after treatment.11 Although the studies in that review used
less strict deﬁnitions of treatment response and remission, the
moderate effects of the present intervention were somewhat
unexpected, because the previous feasibility study had indi-
cated large effects and a larger percentage of treatment
responders and remitters.25 Possible explanations for this
include an overestimation of effects in the pilot trial because
of a smaller sample (N ¼ 21), the use of blinded assessorsJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
VOLUME 56 NUMBER 1 JANUARY 2017and stricter outcome deﬁnitions in the present study, or dif-
ferences in sample characteristics (e.g., more patients having
received CBT before enrollment in the present study).
Interestingly, the effects of ICBT continued beyond the
primary endpoint, with patients experiencing additional
symptom improvement at 3-month follow-up. A comparable
delayed treatment effect also has been found in previous
ICBT trials for childhood anxiety.21,40 This pattern differs
from that of traditional face-to-face CBT, in which most
gains are achieved at posttreatment and then maintained at
follow-up.18,41 Therefore, the effects of ICBT might unfold
more gradually over time compared with face-to-face CBT.
The mean CY-BOCS score at 3-month follow-up was lower
than 15 and largely comparable to many CBT trials in
pediatric OCD.11 Therefore, we believe that our primary
endpoint, set immediately after treatment, underestimates
the true effect of ICBT. An implication for future ICBT
research is that the primary endpoint should be pushed
forward to a later time point.
Although the effects in this trial were smaller than those
usually found in CBT for pediatric OCD, given the notable
savings in clinician time compared with face-to-face CBT,
this treatment could be a cost-effective alternative. Cost data
were collected in this trial, and the corresponding cost-
effectiveness analyses will be presented in a separate report.
The present results are limited by the choice of a waitlist
comparison, which does not allow for control of unspeciﬁc
treatment factors (e.g., attention of a clinician and expec-
tancy effects). However, because ICBT targets individuals
who otherwise would not receive any treatment at all, which
is the case for most patients, we believe that a no-treatment
condition is a valid choice for the patient population of
interest. Nevertheless, further comparisons with an active
control condition and face-to-face CBT are warranted.www.jaacap.org 17
LENHARD et al.Another limitation was that the 3-month follow-up time
point was uncontrolled, because patients on the waitlist had
crossed over to ICBT by that time. This was done for ethical
and practical reasons, but it limits the conclusions regarding
the long-term durability of the results. Moreover, the sample
was largely self-referred, highly educated, and relatively
treatment-naive; therefore, the results might not generalize
to more complex patient populations seen in specialist OCD
clinics.
To summarize, therapist-guided ICBT is an efﬁcacious,
feasible, and safe intervention for adolescents with OCD.
The per-patient clinician time spent supporting the patients
was approximately a third to a fourth the time that would
have been necessary in standard face-to-face CBT, suggest-
ing that ICBT has great potential to increase the capacity of
mental health services to treat more patients with the
available resources. Some patients lived farther than 400 km
from our clinic, indicating that ICBT could be a feasible way
to make CBT more accessible for young people with OCD
who live too far from the nearest specialist clinic. ICBT could
be a promising ﬁrst step in a stepped-care model, freeing
resources for face-to-face CBT and medication as a second
step for nonresponders and/or more complex cases. &
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FIGURE S1 Screenshots from clinician- and parent-supported internet-based cognitive-behavioral therapy (ICBT) program (BiP)
for obsessive-compulsive disorder (OCD).
Overview & start page Messages Psychoeducative 
videos 
Exercise: OCD cycle Exercise: Exposure App support for exposure 
JOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
19.e1 www.jaacap.org VOLUME 56 NUMBER 1 JANUARY 2017
LENHARD et al.
TABLE S1 Estimated Primary and Secondary Continuous
Outcomes of the Intention-to-Treat Sample
Estimated Means (Standard Error)
Pretreatment Posttreatment 3-Mo Follow-Up
Clinician
measurement
CY-BOCS
ICBT 23.00 (0.73) 16.97 (0.82) 14.45 (1.08)
Waitlist 22.12 (0.71) 20.62 (0.82)
Self-ratings
ChOCI-R-C
ICBT 24.48 (1.22) 19.95 (1.34) 18.18 (1.67)
Waitlist 25.38 (1.20) 25.20 (1.30)
CDI-S
ICBT 4.67 (0.62) 4.54 (0.67) 3.50 (0.82)
Waitlist 4.29 (0.61) 4.86 (0.66)
SCAS-S-C
ICBT 12.85 (1.07) 11.45 (1.16) 8.67 (1.41)
Waitlist 13.03 (1.06) 13.45 (1.14)
EWSAS-C
ICBT 14.79 (1.59) 12.33 (1.78) 7.87 (2.15)
Waitlist 15.15 (1.56) 15.64 (1.69)
Parent ratings
ChOCI-R-P
ICBT 24.42 (1.51) 18.75 (1.57) 17.83 (1.82)
Waitlist 25.56 (1.49) 25.13 (1.55)
SCAS-S-P
ICBT 10.70 (0.99) 7.94 (1.01) 8.23 (1.08)
Waitlist 11.76 (0.98) 12.31 (0.99)
EWSAS-P
ICBT 16.12 (1.58) 10.89 (1.60) 10.85 (1.71)
Waitlist 14.15 (1.55) 15.16 (1.58)
FAS-PR
ICBT 15.79 (1.86) 11.13 (1.88) 10.54 (1.99)
Waitlist 16.18 (1.83) 16.92 (1.86)
Note:CDI-S¼ChildDepression InventoryeShortVersion;ChOCI-R-C/P¼Children’s
Obsessional Compulsive Inventory Revised, Child/Parent Version;
CY-BOCS ¼ Children’s Yale-Brown Obsessive Compulsive Scale; EWSAS-C/
P ¼ Education, Work, and Social Adjustment Scale Child/Parent Version; FAS-
PR ¼ Family Accommodation ScaleeParent Report; ICBT ¼ internet-based
cognitive-behavioral therapy; SCAS-S-C/P ¼ Spence Child Anxiety Scale Short
Version for Children/Parents.
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